WallStSmart

Lineage, Inc. Common Stock (LINE)vsRe Max Holding (RMAX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 1765% more annual revenue ($5.36B vs $287.36M). RMAX leads profitability with a 0.1% profit margin vs -2.7%. RMAX earns a higher WallStSmart Score of 36/100 (F).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

RMAX

Hold

36

out of 100

Grade: F

Growth: 2.0Profit: 4.5Value: 3.0Quality: 5.5
Piotroski: 4/9Altman Z: 0.69

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

RMAX1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

RMAX4 concerns · Avg: 3.0/10
Market CapQuality
$611.72M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

Operating MarginProfitability
1.1%3/10

Operating margin of 1.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : RMAX

The strongest argument for RMAX centers on Price/Book.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : RMAX

The primary concerns for RMAX are Market Cap, Return on Equity, Profit Margin. A P/E of 555.0x leaves little room for execution misses. Thin 0.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while RMAX is a value play — different risk/reward profiles.

LINE is growing revenue faster at 0.4% — sustainability is the question.

RMAX generates stronger free cash flow (-4M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RMAX scores higher overall (36/100 vs 34/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.

Visit Website →

Re Max Holding

REAL ESTATE · REAL ESTATE SERVICES · USA

RE / MAX Holdings, Inc. is a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally. The company is headquartered in Denver, Colorado.

Want to dig deeper into these stocks?